Neoplasia/BPH

	Decoding the metabolicâ€‘immune crosstalk: The role of glutamine and ammonium reprogramming in prostate cancer immune evasion (Review). Oncol Rep Wang P, Li X, Ma T, Mi J. PMID: 42663286 [PubMed - indexed for MEDLINE]
	Clinical Evaluation of Urinary VOCs as Non-Invasive Biomarkers in Prostate Cancer. Asian Pac J Cancer Prev Piyarom C, Chalermwat S, Aekgawong S, Kongnawakun D, Anakkamatee W, Pechbooranin A. PMID: 42663226 [PubMed - indexed for MEDLINE]
	Association of Single-Nucleotide Polymorphisms, rs693 and rs1042031, in the APOB Gene with the Risk of Prostatic Diseases among Lebanese Males. Asian Pac J Cancer Prev Sheehan B, Dority C, Springle K, George J, Zaidan WR, El-Saidi MA, El Ezzi AA, Kuddus RH. PMID: 42663203 [PubMed - indexed for MEDLINE]
	"I Have Always Existed, but Never Been Noticed": A Hermeneutic Phenomenological Study of Social Frailty Among Prostate Cancer Survivors. J Multidiscip Healthc Ye J, Zhuang S, Gu Y, Li N, Wan Y, Shen L, Xie C. PMID: 42662832 [PubMed]
	Central and peripheral areal BMD, bone microarchitecture, and strength after initiation of androgen deprivation therapy in men with prostate cancer: a two-year follow-up study. Front Endocrinol (Lausanne) van Oostwaard MM, Bevers MSAM, Driessen JHM, Wyers CE, van den Bergh JP. PMID: 42662144 [PubMed - indexed for MEDLINE]
	Difficult conversations in bladder cancer survivorship: Integrating mental health and intimacy into routine urologic care. Bladder Cancer Smith AK, Wittmann D, Emodi K, Dykstra G, Billings B, Sullivan M, Dunn MW, Treisman GJ. PMID: 42662119 [PubMed]
	Summary of the best evidence for whole-course nutritional management of bladder cancer. Front Nutr Zhang B, Chen Y, Wang Y, Liu Y, Yu X, Xie H. PMID: 42661641 [PubMed]
	Real-World Outcomes of Olaparib in Japanese Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer: Exploratory Analysis of BRCA2 Loss and Microsatellite Instability Status. Int J Urol Nukaya T, Naiki T, Watanabe H, Nakane K, Inamoto T, Yasui T, Koie T, Takahara K. PMID: 42661511 [PubMed - indexed for MEDLINE]
	Development and pilot testing of a prostate cancer polygenic risk report. BMC Med Genomics Griffin JN, Danowski ME, Gerety HL, Lafferty K, Clayman ML, Antwi AA, Bertero MG, Brunette CA, Gillespie C, Guentert L, Lennon NJ, Martin J, Patel LS, Vassy JL. PMID: 42661205 [PubMed - indexed for MEDLINE]
	ctDNA-guided or ctDNA-stratified adjuvant immunotherapy compared with observation or placebo after radical surgery for muscle-invasive urothelial carcinoma: a GRADE-assessed systematic review and meta-analysis. World J Urol Mirza W, Hussain K, Anwaar A, Shaikh A, Sajid MF, Irfan W, Ali RN. PMID: 42661024 [PubMed - indexed for MEDLINE]
	An Apparent Diffusion Coefficient-Based Radiomics Tool for Clinically Significant Prostate Cancer Detection in PI-RADS 3 Lesions: A Multicenter Study. Acad Radiol Gao G, Wang K, Wang X, Liu Y, Gong K, Wu P, Li J, Liu M, Wang M, Hu J, Fan B, Nie S, Liu T, Shi G, Niu S, Qin N. PMID: 42660733 [PubMed - as supplied by publisher]
	Electrochemical biosensing of non-coding RNAs for prostate Cancer diagnosis and prognosis. Clin Chim Acta Roudsari ZO, Vafadar A, Altalbawy FMA, Gafarov R, Mamedova G, Abbas ZK, Movahedpour A, Ghasemi H, Aiiashi S. PMID: 42660441 [PubMed - as supplied by publisher]
	Genetic variation in oxidative stress and detoxification pathways associated with prostate cancer susceptibility: a pathway-based analysis. Free Radic Biol Med Álvarez-González B, Morales-Álvarez CM, Porras-Quesada P, Chica-Redecillas L, Cañadas-Garre M, Hernández AF, Álvarez-Cubero MJ, Martínez-González LJ. PMID: 42660330 [PubMed - as supplied by publisher]
	Prehabilitation models in patients undergoing radical prostatectomy: A scoping review. PLoS One Li Y, Chen Q, Chen H, Chen Y, Huang X, Li H. PMID: 42659628 [PubMed - indexed for MEDLINE]
	Genomic Landscape of Metastatic Urothelial Cancer in a Multicenter Cohort From Argentina. JCO Glob Oncol Cayol F, Macharashvili I, Barochiner J, Dominguez MP, Menna E, Perez Mesa PJ, Pandolfi J, Carranza O, Sanchez R, Marchioni A, Gueron G, Pena L, Cerini M, Cutuli H, Rivello HG, Taetti G, Camacho AF. PMID: 42659586 [PubMed - indexed for MEDLINE]
	Disparities in disease profiles among Afro-Brazilians and public healthcare patients with prostate cancer: real-world data from Brazil. Einstein (Sao Paulo) Nagy ALS, Vazquez YG, Sousa YG, Centrone NY, Rocioli Junior UD, Tustumi F, Moura F, Maluf F, Usón Junior PLS. PMID: 42659448 [PubMed - indexed for MEDLINE]
	Advancing Homologous Recombination Repair Mutation Testing in Prostate Cancer in Australia: Shifting the Focus to Hormone Sensitive Prostate Cancer. Asia Pac J Clin Oncol Azad AA, Murphy DG, Kwan EM, Joshua AM. PMID: 42658786 [PubMed - as supplied by publisher]
	Navigating PI-RADS 3 Lesions: Reducing Uncertainty and Guiding Prostate Cancer Diagnostic Decision Making. Radiographics Nicola R, Correia ETO, Antunes PM, Lopes Pereira de Borborema C, Schoots IG, Bittencourt LK. PMID: 42658725 [PubMed - indexed for MEDLINE]
	Feasibility of Real-Time Central Risk Assignment for Children's Oncology Group Pediatric Renal Tumor Trials. Pediatr Blood Cancer Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Treece AL, Gratias EJ, Cost NG, Grundy PE, Fernandez CV, Dome JS, Geller JI, AREN03B2 Study Committee. PMID: 42657661 [PubMed - as supplied by publisher]
	Physician- and Patient-Reported Outcomes Following Contemporary Image Guided Intensity Modulated Proton Therapy for Prostate Cancer: Results From the Prospective PRO-Cube Study. Adv Radiat Oncol Sundar S, Chilukuri S, Arjunan M, Kamath R, Sinha A, Palani M, Panda PK, Mullapally SK, Ramani S, Ragavan N, Jawahar P, Amalachandran J, Sharma DS, Jalali R. PMID: 42657230 [PubMed]

Articles 1 - 20 / 190848

Page 1 of 9543



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy